Study brain and memory test changes in Alzheimer’s or mild issues
Treatments studied
Part of Brain & nervous system, Mental health clinical trials.
This study looks at how well people with Alzheimer’s disease (AD) or mild cognitive impairment (MCI) perform on standardized memory/brain tests. It may help researchers understand changes over time, and whether certain types of brain signals or test results track with the condition.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You can walk around and come to the study as an outpatient (not hospitalized)
- You are age 65–100, and someone who knows you well (a “co-informant”) can join the study
- You have a diagnosis of Alzheimer’s disease or mild cognitive impairment (MCI)
- You can understand and agree to participate (you have capacity to give informed consent)
- Your memory/thinking screening scores are low enough (GDS 15-item score of 8 or less)
- You do not have major vision or hearing problems that would interfere with testing
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study enrolls people with no memory impairment, mild memory problems, or mild Alzheimer’s dementia to test how brain scans and cognitive tests relate to Alzheimer’s disease. It may help by contributing to better early diagnosis and by letting you see whether you fit into the study’s imaging and blood-test pathway.
This study looks at memory and thinking changes using questionnaires, memory testing, and brain scans. It may help researchers better understand neurodegeneration and dementia and how these problems show up over time.
This study looks at how common mild cognitive impairment and dementia are in people staying in rehabilitation units for heart, lung, or orthopedic problems. It aims to understand memory and thinking issues that may be overlooked in these settings.
This trial is testing an experimental medicine called QLH2405 in two groups: healthy volunteers (to check safety) and people with mild memory problems due to Alzheimer's. If you qualify, the study may help find out if this new treatment is safe and could slow down memory decline.
This study tests a combination of brain stimulation (TMS) and cognitive training to improve memory and thinking in people with mild Alzheimer's. It may help if you are already on a stable dose of a donepezil-type medication and have a confirmed Alzheimer's diagnosis.
This study is testing a new way to measure memory and thinking in people with Alzheimer's disease. Taking part could help researchers find better tools to track the disease and might help you understand your own condition better.
Hear when a new Dementia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.